147 related articles for article (PubMed ID: 32142715)
1. Considerations for Determining Direct Versus Indirect Functional Effects of Solubilizing Excipients on Drug Transporters for Enhancing Bioavailability.
Lavan M; Knipp G
J Pharm Sci; 2020 Jun; 109(6):1833-1845. PubMed ID: 32142715
[TBL] [Abstract][Full Text] [Related]
2. Active intestinal drug absorption and the solubility-permeability interplay.
Porat D; Dahan A
Int J Pharm; 2018 Feb; 537(1-2):84-93. PubMed ID: 29102702
[TBL] [Abstract][Full Text] [Related]
3. Danazol oral absorption modelling in the fasted dog: An example of mechanistic understanding of formulation effects on drug pharmacokinetics.
Pade D; Jamei M; Turner DB; Mistry B; Martinez MN
Eur J Pharm Biopharm; 2019 Aug; 141():191-209. PubMed ID: 31150808
[TBL] [Abstract][Full Text] [Related]
4. The effects of excipients on transporter mediated absorption.
Goole J; Lindley DJ; Roth W; Carl SM; Amighi K; Kauffmann JM; Knipp GT
Int J Pharm; 2010 Jun; 393(1-2):17-31. PubMed ID: 20417699
[TBL] [Abstract][Full Text] [Related]
5. Impact of excipient interactions on drug bioavailability from solid dosage forms.
Panakanti R; Narang AS
Pharm Res; 2012 Oct; 29(10):2639-59. PubMed ID: 22610283
[TBL] [Abstract][Full Text] [Related]
6. The effects of common solubilizing agents on the intestinal membrane barrier functions and membrane toxicity in rats.
Hamid KA; Katsumi H; Sakane T; Yamamoto A
Int J Pharm; 2009 Sep; 379(1):100-8. PubMed ID: 19555752
[TBL] [Abstract][Full Text] [Related]
7. Interplay of metabolism and transport in determining oral drug absorption and gut wall metabolism: a simulation assessment using the "Advanced Dissolution, Absorption, Metabolism (ADAM)" model.
Darwich AS; Neuhoff S; Jamei M; Rostami-Hodjegan A
Curr Drug Metab; 2010 Nov; 11(9):716-29. PubMed ID: 21189140
[TBL] [Abstract][Full Text] [Related]
8. Effect of solubilizing excipients on permeation of poorly water-soluble compounds across Caco-2 cell monolayers.
Saha P; Kou JH
Eur J Pharm Biopharm; 2000 Nov; 50(3):403-11. PubMed ID: 11072198
[TBL] [Abstract][Full Text] [Related]
9. Enhancing the Oral Absorption of Kinase Inhibitors Using Lipophilic Salts and Lipid-Based Formulations.
Williams HD; Ford L; Han S; Tangso KJ; Lim S; Shackleford DM; Vodak DT; Benameur H; Pouton CW; Scammells PJ; Porter CJH
Mol Pharm; 2018 Dec; 15(12):5678-5696. PubMed ID: 30376336
[TBL] [Abstract][Full Text] [Related]
10. Methacrylate-Copolymer Eudragit EPO as a Solubility-Enabling Excipient for Anionic Drugs: Investigation of Drug Solubility, Intestinal Permeability, and Their Interplay.
Fine-Shamir N; Dahan A
Mol Pharm; 2019 Jul; 16(7):2884-2891. PubMed ID: 31120762
[TBL] [Abstract][Full Text] [Related]
11. Using Physiologically Based Pharmacokinetic (PBPK) Modeling to Evaluate the Impact of Pharmaceutical Excipients on Oral Drug Absorption: Sensitivity Analyses.
Chow EC; Talattof A; Tsakalozou E; Fan J; Zhao L; Zhang X
AAPS J; 2016 Nov; 18(6):1500-1511. PubMed ID: 27520379
[TBL] [Abstract][Full Text] [Related]
12. Kolliphor surfactants affect solubilization and bioavailability of fenofibrate. Studies of in vitro digestion and absorption in rats.
Berthelsen R; Holm R; Jacobsen J; Kristensen J; Abrahamsson B; Müllertz A
Mol Pharm; 2015 Apr; 12(4):1062-71. PubMed ID: 25679417
[TBL] [Abstract][Full Text] [Related]
13. A win-win solution in oral delivery of lipophilic drugs: supersaturation via amorphous solid dispersions increases apparent solubility without sacrifice of intestinal membrane permeability.
Miller JM; Beig A; Carr RA; Spence JK; Dahan A
Mol Pharm; 2012 Jul; 9(7):2009-16. PubMed ID: 22632106
[TBL] [Abstract][Full Text] [Related]
14. The effects of three absorption-modifying critical excipients on the in vivo intestinal absorption of six model compounds in rats and dogs.
Dahlgren D; Roos C; Johansson P; Tannergren C; Lundqvist A; Langguth P; Sjöblom M; Sjögren E; Lennernäs H
Int J Pharm; 2018 Aug; 547(1-2):158-168. PubMed ID: 29758344
[TBL] [Abstract][Full Text] [Related]
15. A Critical Overview of the Biological Effects of Excipients (Part I): Impact on Gastrointestinal Absorption.
Martinez MN; Sinko B; Wu F; Flanagan T; Borbás E; Tsakalozou E; Giacomini KM
AAPS J; 2022 May; 24(3):60. PubMed ID: 35501614
[TBL] [Abstract][Full Text] [Related]
16. Analysis of the enhanced oral bioavailability of fenofibrate lipid formulations in fasted humans using an in vitro-in silico-in vivo approach.
Fei Y; Kostewicz ES; Sheu MT; Dressman JB
Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt B):1274-84. PubMed ID: 23500116
[TBL] [Abstract][Full Text] [Related]
17. Biopharmaceutical classification of poorly soluble drugs with respect to "enabling formulations".
Buckley ST; Frank KJ; Fricker G; Brandl M
Eur J Pharm Sci; 2013 Sep; 50(1):8-16. PubMed ID: 23583787
[TBL] [Abstract][Full Text] [Related]
18. Role of lipid-based excipients and their composition on the bioavailability of antiretroviral self-emulsifying formulations.
Chudasama A; Patel V; Nivsarkar M; Vasu K; Shishoo C
Drug Deliv; 2015; 22(4):531-40. PubMed ID: 24601856
[TBL] [Abstract][Full Text] [Related]
19. Comparative studies of the effects of novel excipients amino acids with cyclodextrins on enhancement of dissolution and oral bioavailability of the non-ionizable drug carbamazepine.
Abou-Taleb HA; Fathalla Z; Abdelkader H
Eur J Pharm Sci; 2020 Dec; 155():105562. PubMed ID: 32966851
[TBL] [Abstract][Full Text] [Related]
20. The biopharmaceutical classification system of excipients.
Vasconcelos T; Marques S; Sarmento B
Ther Deliv; 2017 Feb; 8(2):65-78. PubMed ID: 28088879
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
